Copay Assistance – Good For Patients, Bad For Prices
Peter Bach and I have an essay in the Annals of Internal Medicine laying out some of the problems with pharmaceutical funded copay assistance programs. Check it out.
Peter Bach and I have an essay in the Annals of Internal Medicine laying out some of the problems with pharmaceutical funded copay assistance programs. Check it out.
ICYMI: When people watch action movies, they consume more calories.
Russell Wilson took a hard hit to the head in the NFC Championship game last year against the Green Bay Packers. His team, the Seattle Seahawks, won the game, but would Wilson, the team’s star quarterback, recover in time for the next game? That game, by the way, goes by the name The Super Bowl….
Here is what one group of experts thought:
Imagine that you are gasping for breath, literally on the verge of death. Then someone injects you with a medicine and – miracle! – you are perfectly healthy again. Would you pay $300 for that injection? The treatment is epinephrine; your illness was a life-threatening allergy. And that $300 price? That reflects a six-fold increase…
It is notoriously difficult to change physician behavior. When it’s discovered that primary care physicians are, say, prescribing too few cholesterol pills or too many antibiotics, it will not be easy to change those behaviors. Physicians are strong-willed people, with lots of things competing for their attention and with many well ingrained habits. That’s why…
Here’s a picture from a New England Journal of Medicine article showing that in 2015 and 2016, Obamacare premiums grew more slowly than private insurance premiums rose before the law came into effect: The Obamacare markets are new and unsettled. But so far they aren’t leading to runaway inflation. But what will happen to these…